HUTCHMED (China) (HCM) Competitor Comparison
We are evaluating the key criteria listed to compare HUTCHMED (China) (HCM) against its competitors in the Biotechnology industry.
Market Capitalization
62 / 368Gross Profits
270 / 278Total Revenue
21 / 300EBITDA
192 / 337Free Cashflow
277 / 352Quick Ratio
260 / 357Earnings per Share
59 / 359Dividend yield
0 / 6Total Cash
29 / 358Performance 3 years
145 / 368Performance 5 years
153 / 368Performance 10 years
90 / 368Linearity 3 years
97 / 368Linearity 5 years
54 / 368Linearity 10 years
20 / 368Total Rank
145 / 368Dividend Rank
149 / 368Valuation Rank
120 / 368Piotroski Rank
286 / 368Muliplier Rank
108 / 368Linearity 3 years - HCM ranking 97 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.